Follow
Devoogdt
Devoogdt
ICMI VUB
Verified email at vub.be
Title
Cited by
Cited by
Year
Bone marrow-derived monocytes give rise to self-renewing and fully differentiated Kupffer cells
CL Scott, F Zheng, P De Baetselier, L Martens, Y Saeys, S De Prijck, ...
Nature communications 7 (1), 10321, 2016
7472016
Specific cell targeting with nanobody conjugated branched gold nanoparticles for photothermal therapy
B Van de Broek, N Devoogdt, A D’Hollander, HL Gijs, K Jans, L Lagae, ...
ACS nano 5 (6), 4319-4328, 2011
4162011
Phase I study of 68Ga-HER2-nanobody for PET/CT assessment of HER2 expression in breast carcinoma
M Keyaerts, C Xavier, J Heemskerk, N Devoogdt, H Everaert, C Ackaert, ...
Journal of Nuclear Medicine 57 (1), 27-33, 2016
3832016
Nanobodies and their potential applications
G Hassanzadeh-Ghassabeh, N Devoogdt, P De Pauw, C Vincke, ...
Nanomedicine 8 (6), 1013-1026, 2013
3592013
Preclinical screening of anti‐HER2 nanobodies for molecular imaging of breast cancer
I Vaneycken, N Devoogdt, N Van Gassen, C Vincke, C Xavier, U Wernery, ...
The FASEB Journal 25 (7), 2433-2446, 2011
3382011
Nanobody-based targeting of the macrophage mannose receptor for effective in vivo imaging of tumor-associated macrophages
K Movahedi, S Schoonooghe, D Laoui, I Houbracken, W Waelput, ...
Cancer research 72 (16), 4165-4177, 2012
3192012
Synthesis, preclinical validation, dosimetry, and toxicity of 68Ga-NOTA-anti-HER2 Nanobodies for iPET imaging of HER2 receptor expression in cancer
C Xavier, I Vaneycken, M D’huyvetter, J Heemskerk, M Keyaerts, C Vincke, ...
Journal of Nuclear Medicine 54 (5), 776-784, 2013
2252013
Nanobodies targeting mouse/human VCAM1 for the nuclear imaging of atherosclerotic lesions
A Broisat, S Hernot, J Toczek, J De Vos, LM Riou, S Martin, M Ahmadi, ...
Circulation research 110 (7), 927-937, 2012
2252012
Targeted radionuclide therapy with A 177Lu-labeled anti-HER2 nanobody
M D'Huyvetter, C Vincke, C Xavier, A Aerts, N Impens, S Baatout, ...
Theranostics 4 (7), 708, 2014
2032014
Generation of single domain antibody fragments derived from camelids and generation of manifold constructs
C Vincke, C Gutiérrez, U Wernery, N Devoogdt, ...
Antibody Engineering: Methods and Protocols, Second Edition, 145-176, 2012
1652012
Site-specific labeling of cysteine-tagged camelid single-domain antibody-fragments for use in molecular imaging
S Massa, C Xavier, J De Vos, V Caveliers, T Lahoutte, S Muyldermans, ...
Bioconjugate chemistry 25 (5), 979-988, 2014
1632014
Immuno-imaging using nanobodies
I Vaneycken, M D’huyvetter, S Hernot, J De Vos, C Xavier, N Devoogdt, ...
Current Opinion in Biotechnology 22 (6), 877-881, 2011
1592011
Targeted alpha therapy using short-lived alpha-particles and the promise of nanobodies as targeting vehicle
Y Dekempeneer, M Keyaerts, A Krasniqi, J Puttemans, S Muyldermans, ...
Expert opinion on biological therapy 16 (8), 1035-1047, 2016
1522016
PET imaging of macrophage mannose receptor–expressing macrophages in tumor stroma using 18F-radiolabeled camelid single-domain antibody fragments
A Blykers, S Schoonooghe, C Xavier, K D’hoe, D Laoui, M D’Huyvetter, ...
Journal of Nuclear Medicine 56 (8), 1265-1271, 2015
1492015
In vitro analysis and in vivo tumor targeting of a humanized, grafted nanobody in mice using pinhole SPECT/micro-CT
I Vaneycken, J Govaert, C Vincke, V Caveliers, T Lahoutte, ...
Journal of Nuclear Medicine 51 (7), 1099-1106, 2010
1462010
131I-labeled Anti-HER2 Camelid sdAb as a Theranostic Tool in Cancer Treatment
M D'Huyvetter, J De Vos, C Xavier, M Pruszynski, YGJ Sterckx, S Massa, ...
Clinical cancer research 23 (21), 6616-6628, 2017
1432017
Localization, mechanism and reduction of renal retention of technetium‐99m labeled epidermal growth factor receptor‐specific nanobody in mice
LO Tchouate Gainkam, V Caveliers, N Devoogdt, C Vanhove, C Xavier, ...
Contrast media & molecular imaging 6 (2), 85-92, 2011
1412011
Size and affinity kinetics of nanobodies influence targeting and penetration of solid tumours
P Debie, C Lafont, M Defrise, I Hansen, DM van Willigen, ...
Journal of controlled release 317, 34-42, 2020
1382020
Camelid single-domain antibody-fragment engineering for (pre)clinical in vivo molecular imaging applications: adjusting the bullet to its target
J De Vos, N Devoogdt, T Lahoutte, S Muyldermans
Expert opinion on biological therapy 13 (8), 1149-1160, 2013
1382013
Secretory leukocyte protease inhibitor promotes the tumorigenic and metastatic potential of cancer cells
N Devoogdt, G Hassanzadeh Ghassabeh, J Zhang, L Brys, ...
Proceedings of the National Academy of Sciences 100 (10), 5778-5782, 2003
1322003
The system can't perform the operation now. Try again later.
Articles 1–20